COMMUNIQUÉS West-GlobeNewswire
-
Cannabis education starts before legal age of consumption
03/10/2018 - 17:08 -
Molina Healthcare Announces Third Quarter 2018 Earnings Release and Conference Call Dates
03/10/2018 - 17:00 -
The Right to Be Treated: Overcoming Bias & Discrimination in Obesity Care
03/10/2018 - 16:27 -
Xyngular Named One of Inc. 5000’s Fastest Growing Companies in America for 3rd Year in a Row
03/10/2018 - 16:03 -
Aura Appoints New Director
03/10/2018 - 15:58 -
The Alliance for Regenerative Medicine Announces Election of 2019 ARM Officers, Executive Committee, and Board of Directors
03/10/2018 - 15:00 -
Medibio Releases Corporate Health Product, ilumen™
03/10/2018 - 15:00 -
The Race to Speed Up the Effects of Cannabis -- CFN Media
03/10/2018 - 15:00 -
Phoenix Life Sciences International Announces New Board of Directors and Executive Team
03/10/2018 - 15:00 -
CENTOGENE and Denali Therapeutics Announce Strategic Collaboration to Recruit LRRK2 Patients for Clinical Trials
03/10/2018 - 15:00 -
Technology Innovators, Experienced Systems Integrators Join Cerner in Mission to Modernize Veterans' Electronic Health Records
03/10/2018 - 15:00 -
MannKind Presents New Scientific Data at 54th Annual Meeting of the European Association for the Study of Diabetes
03/10/2018 - 15:00 -
Cue Biopharma Appoints Hon. Randall R. Rader to Chair Company’s Intellectual Property Committee
03/10/2018 - 15:00 -
CymaBay Therapeutics Announces Additional Positive Results from its Ongoing Phase 2 Study of Seladelpar in Patients with PBC will be Presented During the Late-Breaking Session at The Liver Meeting®
03/10/2018 - 15:00 -
JSC Olainfarm holds Second Quarter 2018 Investor Conference Webinar
03/10/2018 - 14:49 -
Scythian Biosciences Appoints Brady Cobb as CEO
03/10/2018 - 14:41 -
Zosano Pharma Engages Contract Manufacturer as Part of the Commercialization Strategy for M207
03/10/2018 - 14:30 -
VistaGen Therapeutics Receives FDA Fast Track Designation for Development of AV-101 as a Non-Opioid Treatment for Neuropathic Pain
03/10/2018 - 14:30 -
Aleafia Announces Options Grant
03/10/2018 - 14:20
Pages